Selected article for: "mass spectrometry and previous study"

Title: 2015 ACVIM Forum Research Abstract Program
  • Document date: 2015_5_27
  • ID: 3pnuj5ru_762
    Snippet: Three purpose-bred cats with unremarkable CBC, serum biochemistry and urinalyses were utilized. The following procedures were performed (minimum 7 day wash out): A) 3.75 mg and 7.5 mg TM once aurally with 48 hour PK sampling (Serum samples were obtained via jugular catheter at 0, 0.5, 1, 2, 5, 9, 12, 24, 36 and 48 hours) , B) 7.5 mg TM and placebo daily aurally for six consecutive days then 48 hour PK C) 1.87 mg mirtazapine orally once with limit.....
    Document: Three purpose-bred cats with unremarkable CBC, serum biochemistry and urinalyses were utilized. The following procedures were performed (minimum 7 day wash out): A) 3.75 mg and 7.5 mg TM once aurally with 48 hour PK sampling (Serum samples were obtained via jugular catheter at 0, 0.5, 1, 2, 5, 9, 12, 24, 36 and 48 hours) , B) 7.5 mg TM and placebo daily aurally for six consecutive days then 48 hour PK C) 1.87 mg mirtazapine orally once with limited serum sampling at 1, 4 and 8 hours. Kibble weight was recorded every 2 hours during B and C. Serum mirtazapine and compounded gel concentrations were measured using liquid chromatography/tandem mass spectrometry. Non-compartmental pharmacokinetic modeling was performed. Oral dose AUC values were estimated using a limited sampling model developed from previous study data.

    Search related documents:
    Co phrase search for related documents